Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Public ClinicalTrials.gov record NCT04806620. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Unhide® Project Also Known as The Unhide® Solve Together Unified Platform
Study identification
- NCT ID
- NCT04806620
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Brain Inflammation Collaborative
- Other
- Enrollment
- 10,000 participants
Conditions and interventions
Conditions
- ARFID
- Ankylosing Spondylitis (AS)
- Anorexia Nervosa
- Autoimmune Diseases
- Autoimmune Encephalitis
- Avoidant / Restrictive Food Intake Disorder
- Bulimia Nervosa
- Celiac Disease
- Celiac Disease in Children
- Chronic Lyme Disease
- Crohn's Disease
- Dysautonomia
- Ehlers Danlos Syndrome
- Endometriosis
- Fibromyalgia (FM)
- General Anxiety Disorder, Social Anxiety Disorder
- Inflammatory Bowel Disease (IBD)
- Juvenile Rheumatoid Arthritis (JRA)
- Long COVID
- Lupus
- ME/CFS
- Mast Cell Activation Syndrome
- Migraines
- Multiple Sclerosis
- Myalgic Encephalomyelitis (ME)
- Myasthenia Gravis in Children
- Myasthenia Gravis, Generalized
- Narcolepsy
- Neurological Diseases or Conditions
- Obsessive Compulsive Disorder (OCD)
- PANDAS
- POTS - Postural Orthostatic Tachycardia Syndrome
- PTSD - Post Traumatic Stress Disorder
- Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)
- Post-Acute COVID-19 Syndrome
- Post-treatment Lyme Disease Syndrome
- Psoriasis
- Psoriatic Arthritis (PsA)
- Psychiatric Disorder
- Rheumatic Arthritis
- Sjogren's Syndrome
- Tourette's Syndrome
- Traumatic Brain Injury
- Ulcerative Colitis and Crohn's Disease
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 2 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 4, 2023
- Primary completion
- Jun 29, 2030
- Completion
- Dec 30, 2030
- Last update posted
- Jan 21, 2026
2023 – 2030
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Brain Inflammation Collaborative | Delafield | Wisconsin | 53018 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04806620, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 21, 2026 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04806620 live on ClinicalTrials.gov.